Bristol-Myers is the next big tenant in biotech’s hottest neighborhood

Damian Garde

Bristol-Myers Squibb's latest R&D reshuffle calls for a consolidated presence in Cambridge, MA's booming Kendall Square, and the drugmaker has signed on to serve as anchor in the area's big research facility, joining Big Pharma's ongoing colonization of a biotech hotbed.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS